Protein size range |
Average size of solved structures is ~100 kDa [7]. |
Typically above 100 kDa. Volta Phase plates have been used to boost signal-to-noise for smaller proteins or binders such as Fabs and megabodies can be used to increase particle size [163,217]. |
Sample heterogeneity |
Usually a homogeneous sample is required [229]. |
Can tolerate some sample heterogeneity but homogeneous samples lead more quickly to higher resolution structures [216]. |
Sample concentration |
Large quantities of pure protein [230]. Typically 100 to 200 µL at 5 to 40 mg mL−1. |
Small quantities of pure protein [230]. Less than 10 to 100 µL at 0.5 to 5 mg mL−1. |
Sample preparation |
Relies on obtaining diffracting MP crystals which are difficult to obtain. MP must be removed from its native environment. Crystals grown in crystallisation trays, mounted in a loop and cryo-cooled in liquid nitrogen [171]. |
MP blotted on to EM grids and vitrified in liquid ethane [110,231]. Single particle analysis can be carried out on proteoliposomes providing a more native environment [232]. |
Screening throughput |
High. Typically in 96 well plates, allowing 100s of conditions to be sampled simultaneously [171]. |
Low. Each condition to be screened must be imaged individually. Negative stain can be used to narrow screening conditions [216]. |
Collection method |
X-ray diffraction of protein in crystalline lattice, typically using a synchrotron source [171]. Microcrystal electron diffraction is an area of increasing interest [233]. |
Electron imaging in conjunction with a direct electron detector. Energy filters and phase plates may be helpful [234]. |
Collection throughput |
High. Typically, 15–30 crystals per hour [7]. |
Low. Time taken several orders of magnitude behind X-ray crystallography [235]. |
Data Analysis |
Quick and highly automated. Complete datasets can be collected in seconds. Many synchrotrons have automated processing pipelines integrated into the data collection process [7]. Well established software suites such as CCP4i2 to aid the crystallographer [236]. |
Slow. Reconstructions from 1000s of single images can take many days. Processing pipeline can be automated. Software packages to analyse data less established but constantly improving. Examples include RELION and cryoSPARC [237,238]. |
Structure-based drug design |
Routine, high resolution and high throughput. Well established for GPCRs [13,239]. |
Currently lacks reproducibility, quality and throughput. Ideally requires protein structures at a resolution of less than 3 Å [240,241]. |
MP conformational flexibility |
Each crystal form relates to a single rigid MP conformation. |
MP can be in different conformations, which can be identified during processing (but also impede processing) [216]. |
Ion identification |
Generally straightforward depending on resolution. Long-wavelength beamlines enables sodium ion to be distinguished from a potassium ions [228]. |
Difficult to identify some anions ions in maps due to negative scattering factors [242]. Electrostatic potential maps may help to overcome this [243]. |
Resolution |
Typical range between 1.5 Å and 3.5 Å. For MPs crystallised in LCP Sub 2.5 Å are common. Highest resolution structure currently a yeast aquaporin at 0.88 Å, PDB: 3ZOJ [244]. |
Typically, 2.5–4 Å are common including some smaller membrane proteins [217]. Highest resolution structure currently the β3 GABAA receptor homopentamer at 1.7 Å, PDB: 7A5V [219]. EM density maps can identify protein and ion charge states [242]. |